Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,201 | 9,864 | 12,130 | 13,048 | 6,461 |
| Receivables | N/A | N/A | N/A | N/A | 883 |
| Other current assets | 46 | 44 | 14 | 21 | 21 |
| TOTAL | $8,103 | $11,392 | $14,138 | $13,722 | $8,659 |
| Non-Current Assets | |||||
| PPE Net | 18 | 3 | 4 | 5 | 6 |
| Other Non-Current Assets | 503 | 474 | 366 | 22 | 36 |
| TOTAL | $521 | $478 | $370 | $27 | $42 |
| Total Assets | $8,624 | $11,869 | $14,508 | $13,749 | $8,701 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,772 | 1,928 | 1,261 | 2,569 | 2,198 |
| TOTAL | $4,101 | $1,959 | $1,383 | $2,779 | $2,524 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,101 | $1,959 | $1,383 | $2,779 | $2,524 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 811 | 620 | 575 | 455 | 245 |
| Common Shares | 1 | 1 | 1 | 3 | 0 |
| Retained earnings | -100,275 | -94,320 | -91,101 | -88,726 | -84,425 |
| TOTAL | $4,523 | $9,910 | $13,125 | $10,970 | $6,177 |
| Total Liabilities And Equity | $8,624 | $11,869 | $14,508 | $13,749 | $8,701 |